5596 related articles for article (PubMed ID: 3699929)
1. A radioimmunoassay for the detection of a human tumor-associated glycoprotein (TAG-72) using monoclonal antibody B72.3.
Paterson AJ; Schlom J; Sears HF; Bennett J; Colcher D
Int J Cancer; 1986 May; 37(5):659-66. PubMed ID: 3699929
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
[TBL] [Abstract][Full Text] [Related]
3. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein.
Horan Hand P; Colcher D; Salomon D; Ridge J; Noguchi P; Schlom J
Cancer Res; 1985 Feb; 45(2):833-40. PubMed ID: 3881173
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas.
Katari RS; Fernsten PD; Schlom J
Cancer Res; 1990 Aug; 50(16):4885-90. PubMed ID: 2379152
[TBL] [Abstract][Full Text] [Related]
5. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.
Thor A; Ohuchi N; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1986 Jun; 46(6):3118-24. PubMed ID: 3516392
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72).
Klug TL; Sattler MA; Colcher D; Schlom J
Int J Cancer; 1986 Nov; 38(5):661-9. PubMed ID: 2429934
[TBL] [Abstract][Full Text] [Related]
7. Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts.
Colcher D; Keenan AM; Larson SM; Schlom J
Cancer Res; 1984 Dec; 44(12 Pt 1):5744-51. PubMed ID: 6498836
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4.
Pancino G; Osinaga E; Charpin C; Mistro D; Barque JP; Roseto A
Br J Cancer; 1991 Mar; 63(3):390-8. PubMed ID: 1706194
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
10. Studies concerning the effect of external irradiation on localization of radiolabeled monoclonal antibody B72.3 to human colon carcinoma xenografts.
Shrivastav S; Schlom J; Raubitschek A; Molinolo A; Simpson J; Hand PH
Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):721-9. PubMed ID: 2921170
[TBL] [Abstract][Full Text] [Related]
11. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
[TBL] [Abstract][Full Text] [Related]
12. Production of monoclonal antibodies to serum antigens in colorectal carcinoma.
Teh JG; Thompson CH; McKenzie IF
J Immunol Methods; 1988 May; 110(1):101-9. PubMed ID: 3286775
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3.
Esteban JM; Colcher D; Sugarbaker P; Carrasquillo JA; Bryant G; Thor A; Reynolds JC; Larson SM; Schlom J
Int J Cancer; 1987 Jan; 39(1):50-9. PubMed ID: 3793270
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues.
Zhang HZ; Ordonez NG; Batsakis JG; Chan JC
Cancer Res; 1989 Oct; 49(20):5766-73. PubMed ID: 2477148
[TBL] [Abstract][Full Text] [Related]
15. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.
Colcher D; Minelli MF; Roselli M; Muraro R; Simpson-Milenic D; Schlom J
Cancer Res; 1988 Aug; 48(16):4597-603. PubMed ID: 3396011
[TBL] [Abstract][Full Text] [Related]
17. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
18. Surface expression of tumor-associated antigens in primary cultured human colonic epithelial cells from carcinomas, benign tumors, and normal tissues.
Friedman E; Thor A; Hand PH; Schlom J
Cancer Res; 1985 Nov; 45(11 Pt 2):5648-55. PubMed ID: 2413994
[TBL] [Abstract][Full Text] [Related]
19. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3.
Sheer DG; Schlom J; Cooper HL
Cancer Res; 1988 Dec; 48(23):6811-8. PubMed ID: 3180090
[TBL] [Abstract][Full Text] [Related]
20. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
Simpson J; Schlom J
Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
